CVS, UnitedHealth, and Cigna Sue to Block FTC Insulin Price Case
CVS Health, UnitedHealth Group, and Cigna filed a lawsuit against the FTC, arguing the agency’s administrative court proceedings regarding insulin pricing violate their Fifth Amendment due process rights. The companies contend the FTC’s claims, alleging a “perverse” rebate system inflates insulin costs, should be litigated in federal court, not the agency’s internal process. They argue the FTC’s structure lacks democratic accountability, deeming the process fundamentally unfair. The FTC responded that the companies’ constitutional challenge is a distraction from accusations of harming patients through inflated insulin prices. This action follows earlier recusal requests based on alleged commissioner bias.
John Q. Hosedrinker